Estudio Echecopar
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Having left Baker McKenzie's international network in mid-2025, Estudio Echecopar continues to be engaged by a stellar range of investors and global corporations and to lead on significant M&A transactions - particularly in the medical, energy and chemical sectors. Core workflows include advising on the merger control regime, divestments, joint venture agreements, shareholder disputes and corporate arbitration and litigation. Practice head Liliana Espinosa is known for her work on spin-offs, the sale of companies and assets, and private and public M&A. Ines Baca has a track record of dealing with corporate reorganisations and share participations, while Fernando Sam has experience in corporate finance, often acting for multinationals.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Professionalism,’
- ‘The corporate and M&A team at Estudio Echecopar is distinguished by its professional excellence, with highly trained specialists who operate under the highest standards and are constantly updating their knowledge. Their firm commitment and effective communication with clients are qualities that deserve special recognition.’
Key clients
- Mitsubishi Power America
- Inversiones Centenerario
Work highlights
Advised UnitedHealth Group in the sale of its 50% interest in the joint venture initiated with Pacifico Compañia de Seguros y Reaseguros, to Pacifico Seguros.